Page last updated: 2024-09-03

n(alpha)-tosyl-(3-amidinophenyl)alanine piperidide and n-alpha-(2,4,6-triisopropyl-phenylsulfonyl)-3-amidino-(l)-phenyl-alanine-4-ethoxycarbonyl-piperazide hydrochloride

n(alpha)-tosyl-(3-amidinophenyl)alanine piperidide has been researched along with n-alpha-(2,4,6-triisopropyl-phenylsulfonyl)-3-amidino-(l)-phenyl-alanine-4-ethoxycarbonyl-piperazide hydrochloride in 1 studies

Compound Research Comparison

Studies
(n(alpha)-tosyl-(3-amidinophenyl)alanine piperidide)
Trials
(n(alpha)-tosyl-(3-amidinophenyl)alanine piperidide)
Recent Studies (post-2010)
(n(alpha)-tosyl-(3-amidinophenyl)alanine piperidide)
Studies
(n-alpha-(2,4,6-triisopropyl-phenylsulfonyl)-3-amidino-(l)-phenyl-alanine-4-ethoxycarbonyl-piperazide hydrochloride)
Trials
(n-alpha-(2,4,6-triisopropyl-phenylsulfonyl)-3-amidino-(l)-phenyl-alanine-4-ethoxycarbonyl-piperazide hydrochloride)
Recent Studies (post-2010) (n-alpha-(2,4,6-triisopropyl-phenylsulfonyl)-3-amidino-(l)-phenyl-alanine-4-ethoxycarbonyl-piperazide hydrochloride)
1100603

Protein Interaction Comparison

ProteinTaxonomyn(alpha)-tosyl-(3-amidinophenyl)alanine piperidide (IC50)n-alpha-(2,4,6-triisopropyl-phenylsulfonyl)-3-amidino-(l)-phenyl-alanine-4-ethoxycarbonyl-piperazide hydrochloride (IC50)
Urokinase-type plasminogen activatorHomo sapiens (human)0.41

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bode, W; Dönnecke, D; Friedrich, R; Müller, F; Schuster, O; Schweinitz, A; Steinmetzer, P; Steinmetzer, T; Stürzebecher, A; Stürzebecher, J; Than, ME; Uhland, K1

Other Studies

1 other study(ies) available for n(alpha)-tosyl-(3-amidinophenyl)alanine piperidide and n-alpha-(2,4,6-triisopropyl-phenylsulfonyl)-3-amidino-(l)-phenyl-alanine-4-ethoxycarbonyl-piperazide hydrochloride

ArticleYear
Secondary amides of sulfonylated 3-amidinophenylalanine. New potent and selective inhibitors of matriptase.
    Journal of medicinal chemistry, 2006, Jul-13, Volume: 49, Issue:14

    Topics: Amides; Amidines; Animals; Catalytic Domain; Crystallography, X-Ray; Humans; Kinetics; Male; Mice; Mice, Nude; Models, Molecular; Neoplasm Metastasis; Phenylalanine; Prostatic Neoplasms; Serine Endopeptidases; Serine Proteinase Inhibitors; Structure-Activity Relationship; Sulfones; Xenograft Model Antitumor Assays

2006